Treatment as Prevention¨

Over 1,000 Leaders Worldwide Call for End to “Disastrous” Drug War, Ahead of UN Special Session

Former Presidents of Mexico, Colombia, Brazil, Chile, Nigeria, Cape Verde, Switzerland & Poland; Former Prime Ministers of Greece, Hungary & The Netherlands Join With Distinguished Scholars, Jurists, Clergy, Business Leaders, Elected Officials, Celebrities and Others in Calling for Alternatives to Prohibitionist Drug Control Policies “Humankind cannot afford a 21st century drug policy as ineffective and […]

Over 1,000 Leaders Worldwide Call for End to “Disastrous” Drug War, Ahead of UN Special Session Read More »

Highlights from CROI 2016

If there’s one big international HIV conference that’s still worth following, it’s CROI. Geoff Honnor reports on this year’s highlights. There was a time long ago, way back in the late 1990s, when the proceedings of international HIV conferences were of compelling interest to the body positive here in NSW. The biennial World AIDS Conference

Highlights from CROI 2016 Read More »

People not taking HIV treatment feel under pressure to ‘do the right thing’

Australian people living with HIV who have chosen not to take antiretrovirals and who have doubts about HIV medicine report feeling excluded and silenced within HIV organisations and communities, according to a qualitative study published online ahead of print by Medical Anthropology Quarterly. In general, the interviewees did not deny the benefits of antiretrovirals, but

People not taking HIV treatment feel under pressure to ‘do the right thing’ Read More »

Contra el virus HIV/SIDA

Un científico argentino estaría muy cerca de derrotar el virus del VIH/Sida. Se trata del Dr. Julio Montaner. Descubrió el “cóctel antirretroviral o de triple terapia”, la clave para transformar el manejo de la enfermedad. Montaner dedicó los últimos veinte años de su vida científica a investigar sobre el VIH/sida. Supo cómo sitiar al virus

Contra el virus HIV/SIDA Read More »

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below